Clonidine Overdose risk: Medicine Safety Update from TGA

Drug Safety Updates, Global Safety Alerts, Medication Errors, Medicinal Product Updates, Pharmacovigilance, TGA-Australia, Voluntary ADR reporting, ,

Health Authority of Australia – Therapeutic Goods and Administration (TGA), released a new safety update for the safe use of clonidine by disseminating information of potential overdose instances in children. Clonidine is an anti hypertensive medication (used for lowering blood pressure) which acts centrally as alpha-agonist agent. This medicine is also approved for use in…

Read More

TRISENOX (arsenic trioxide) and potential medication errors: DHPC from Teva Pharmaceuticals

Drug Safety Alert, Drug Safety Updates, EMA-European Medicines Agency, Global Safety Alerts, HPRA-Ireland, Medication Errors, Medicinal Product Updates, Pharmacovigilance, Safety Communications, , ,

Arsenic trioxide is a chemotherapeutic medication used in the treatment of newly diagnosed low-to-intermediate risk acute promyelocytic leukaemia (APL) and relapsed/refractory APL characterized by the presence of leukaemia/retinoic-acid-receptor-alpha (PML/RAR-alpha) gene. The initial approved formulation available in market for arsenic trioxide is 1 mg/ml single-use 10 ml of glass ampoule (This formulation comprises 10 mg of…

Read More

error: Content is protected !!